Covid 19 vaccine

The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known…

Moderna said the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group…

Moderna has sped up plans for its experimental COVID-19 vaccine and said it expected to start a late-stage trial in early summer

The statement comes after the French government took objection to Sanofi CEO’s earlier comment that the US will get first access…

"For vaccines, since the development has to start from scratch ... we might look from an optimistic side in a year from now, so…

The combined offer will enable users to rapidly deploy prefabricated GMP vaccine manufacturing facilities in response to the…

Collaboration goal to produce up to one billion doses per year, first batches expected to be manufactured at Lonza US in July 2020

The triple antigen vaccine being developed by Premas Biotech is being designed to try to overcome presently known and possible…

The vaccine will be based on recombinant avian paramyxovirus-based vector platform, the company said

Serum Institute of India will be manufacturing Oxford University's coronavirus vaccine in anticipation of clinical trials…